1981
DOI: 10.1113/expphysiol.1981.sp002556
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Β‐endorphin, Vasoactive Intestinal Polypeptide and Cholecystokinin Octapeptide on Cat Carotid Chemoreceptor Activity

Abstract: The effects of beta-endorphin, vasoactive intestinal polypeptide (VIP) and cholecystokinin octapeptide (CCK-8) on carotid chemoreceptor activity have been investigated in cats anaesthetized with pentobarbitone. Spontaneous chemoreceptor discharge was decreased by intracarotid injection of beta-endorphin and by low doses of VIP, whereas it was increased by CCK-8 and higher doses of VIP, these effects being relatively long-lasting and often associated with changes in systemic blood pressure. The chemoexcitation … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
15
0

Year Published

1986
1986
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(16 citation statements)
references
References 21 publications
1
15
0
Order By: Relevance
“…There was no tendency for opioids to cause marked chemoexcitation following administration of either ICI 154129 or ICI 174864 in our study. In some experiments a slight variable dose-related increase in discharge was obtained with ethylketocyclazocine and dynorphin (1-8), much the same as that observed with P-endorphin following naloxone (McQueen & Ribeiro, 1981b). It is not clear whether these very variable excitatory effects result from actions mediated via opioid receptors, or are non-specific actions ofopioids administered in high doses.…”
Section: Opioid Antagonistsmentioning
confidence: 81%
“…There was no tendency for opioids to cause marked chemoexcitation following administration of either ICI 154129 or ICI 174864 in our study. In some experiments a slight variable dose-related increase in discharge was obtained with ethylketocyclazocine and dynorphin (1-8), much the same as that observed with P-endorphin following naloxone (McQueen & Ribeiro, 1981b). It is not clear whether these very variable excitatory effects result from actions mediated via opioid receptors, or are non-specific actions ofopioids administered in high doses.…”
Section: Opioid Antagonistsmentioning
confidence: 81%
“…Systemic opioids also depress ventilation in animals by mechanisms, including central- (Campbell et al, 1995) and vagal afferent-mediated (Kaczy ska and Szereda-Przestaszewska, 2005) depression of ventilatory drive; skeletal muscle rigidity in the chest-wall and abdomen (Seamman, 1983; Niedhart et al, 1989; Bowdle, 1998); increases in pulmonary airway resistance (Willette et al, 1983); and increases in upper airway resistance via closure of the larynx (Willette et al, 1982, 1987; Bennett et al, 1997). Moreover, agonist-induced activation of central and peripheral opioid receptors blunt the hypoxic ventilatory response (see Zhang et al, 2009), and opioids such morphine and fentanyl inhibit carotid body chemoafferent activity and depress the responses of these afferents to hypoxic and hypercapnic challenges (McQueen and Rubeiro, 1980, 1981; Zimpfer et al, 1983; Kirby and McQueen, 1986; Mayer et al, 1989). Opioids including morphine also negatively affect ventilation-perfusion in the lungs of rabbits (Shafford and Schadt, 2008), pigs (Hannon and Bossone, 1991), dogs (Copland et al, 1987) and rats (Ling et al, 1985; Szikszay et al, 1986).…”
Section: Introductionmentioning
confidence: 99%
“…dorsal and ventral respiratory regions) 9 . The effects of opiates on the carotid body have been studied only in functional experimental studies on animals, which revealed that methionine‐enkephalin, β‐endorphin and morphine decrease spontaneous chemoreceptor discharge 10–12 . Moreover, the carotid chemoreceptor response to hypoxia is enhanced by intravenous injection of naloxone, thus supporting the role of endogenous opiates in basal suppression of the ventilatory effects of peripheral chemoreceptors 12,13 …”
Section: Introductionmentioning
confidence: 99%